Join to access to all OVN content. Join for Free
MSL “GROWTH”…Within the role and BEYOND
Medical Science Liaison career progression transitioning in pharma skill development mentorship in career growth

MSL “GROWTH”…Within the role and BEYOND


Share This Article


Summary

In this episode, Danielle Day, Senior Medical Director at Sobe North America, joins Tom Caravela to share her journey from academia to the MSL role. Danielle discusses her transition, highlighting her first successful interview and hiring experience, and her progression at AstraZeneca. She emphasizes the significance of being proactive, creative, and engaging internally across functions. The conversation explores career paths, the importance of skill development over job titles, and understanding various roles to manage expectations. Danielle provides insights on transitioning within the industry, gaining diverse experiences, and moving into management, underscoring perseverance and mentorship in career growth.

Danielle Day, Senior Medical Director, Immunology, Rare Disease at Sobi - North America discusses how to grow within the MSL role and beyond.

Danielle shares….

👉 Her career progression and how she GREW her career

👉 The importance of being proactive and collaborative

👉 How to take an out of the box approach

👉 Why you need to ask good questions throughout your career

👉 Looking behind the curtain to see how the sausage is made

Click for Source
Medical Science Liaison, career progression, transitioning in pharma, skill development, mentorship in career growth

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
Over-Negotiation-How to Botch a Job Offer
Partner Avatar MSL Talk: Tom Caravela

Over-Negotiation-How to Botch a Job Offer

Article
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
OVN Avatar Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Article
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
OVN Avatar Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Article
Clinical Educator Oncology Program Improves Adherence by 29%​
Partner Avatar iNIZIO

Clinical Educator Oncology Program Improves Adherence by 29%​

Explore OVN